Journal of Neurology

Article	Citations
The deltoid muscle and the pattern of paresis in ALS	154
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	144
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	135
Tacrolimus-induced Parkinsonism	125
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	116
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	103
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	100
Neurological manifestation of HEV infection: still a rare disease entity?	85
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	78
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	78
The DeMyers: Marian (1922–2012) and William (1924–2008)	75
Tourette syndrome: effects of acetyl-leucine in two individuals	67
Richard Caton (1842-1926)	67
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	67
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	65
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	63
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	63
Complications of reversible cerebral vasoconstriction syndrome in relation to age	63
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	63
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	61
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	61
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	61
Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples	59
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	57
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	55

Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	54
Dystonia management across Europe within ERN-RND: current state and future challenges	53
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	52
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	51
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	51
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	50
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	50
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	50
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	50
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	48
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	48
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	47
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	47
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	46
Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy	46
Performance of blind source separation in localizing seizure onset from routine scalp-EEG	46
Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing–remitting multiple sclerosis: a mu	45
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	44
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	43
Neural correlates of dual-task walking in people with central neurological disorders: a systematic review	43
Longitudinal predictors of health-related quality of life in isolated dystonia	43
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	42
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	41
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	40
Perceptual response characterization in acute vestibular implant stimulation	40
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	39
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	39
International survey on the implementation of the European and American guidelines on disorders of consciousness	39
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	39
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	38
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	37
Explaining recovery from coma with multimodal neuroimaging	37
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	37
Primary progressive aphasia: six questions in search of an answer	37
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology	36
Walter Russell Brain (1895–1966)	36
Cavernomas: to treat or not to treat?	36
Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs	36
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration	35
Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome	35
Episodic symptoms caused by neurovascular conflict of vagus nerve due to hemilateral anterior inferior cerebellar artery	35
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry	35
Patent foramen ovale diagnosis in young stroke patients: analysis of recurrence and mortality	34
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19	34
Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation	34
Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus	34
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational study	34
Audiovisual analysis of the diagnostic video polysomnography in patients with isolated REM sleep behavior disorder	33
Air pollution, greenspace exposure and risk of Parkinson's disease: a prospective study of 441,462 participants	33
Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography	33

Regional brain atrophy subtypes in spinocerebellar ataxia type 3: links to clinical performance and treatment response	32
Neurological update: structural and functional imaging in epilepsy surgery	32
The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review	32
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment	32
The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review	32
Endolymphatic space is age-dependent	32
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study	32
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3	32
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective	31
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression	31
Left- vs right-sided migraine: a scoping review	31
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s	31
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry	31
Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop	30
Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients	30
Health-related quality of life in Japanese patients with multiple sclerosis	30
Proposal of new diagnostic criteria for fatal familial insomnia	29
Procedural and Clinical Outcome of Stroke after thrombectomy according to etiology: results from a nationwide registry	29
Genetic modifiers of upper limb function in Duchenne muscular dystrophy	29
eHealth tools to assess the neurological function for research, in absence of the neurologist: a systematic review, part II (hardware)	29
The topography of infratentorial lesions in depression and anxiety in multiple sclerosis	28
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD	28
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial	28
Distributions and network changes of brain activity in the acute phase of anti-NMDAR encephalitis: a MEG study	28
Anti-SOX1 antibody-associated acute hemorrhagic leukoencephalitis	28
Inflammatory neuropathy with evidence of anti-GQ1b antibodies in angioimmunoblastic T cell lymphoma (AITL): a case report	28
Cerebral infarctions following an increase in corticosteroids: an atypical case of reversible cerebral vasoconstriction syndrome	28
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia	28
Sutton’s law applies to functional neurology	28
Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis	28
The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention	27
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report	27
Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme	27
Aphasia as a stroke mimic in older adults: a diagnostic challenge	27
Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis	27
A novel prediction score determining individual clinical outcome 3 months after juvenile stroke (PREDICT-score)	27
Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson’s disease: a double-blind, randomised sham-controlled proof-of-concept study	26
Estimation of ataxia severity in children with ataxia-telangiectasia using ankle-worn sensors	26
Laura Forster (1858–1917)	26
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules	26
Architecture and anatomy of executive processes: evidence from verbal fluency and Trail Making Test in 2009 stroke patients	26
Management of hypersensitivity in a patient with late-onset Pompe disease experiencing recurrent infusion-related reactions	26
The Sternbergers: Ludwig (1921–2008) and Nancy (1938–2014)	26
Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study	26
Evaluating 18F-Florzolotau tau PET for Alzheimer’s disease diagnosis with 18F-Flortaucipir as reference	26
Cognitive stimulation in Parkinson’s disease with mild cognitive impairment	25
Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease	25
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study	25
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia	25
Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19	25
Neurophysiological and behavioural correlates of ocrelizumab therapy on manual dexterity in patients with primary progressive multiple sclerosis	25
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease	25
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study	25
Artificial intelligence in neurology: opportunities, challenges, and policy implications	25
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study	25
Bilateral beaded watershed infarction secondary to acute anemia from gastrointestinal bleeding	25
Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia	25
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors	25
Encephalitis in HIV-infected adults in the antiretroviral therapy era	25
Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder	24
MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions	24
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy	24
Beneficial effect of N-acetyl-DL-leucine on cognitive function, emotional well-being and QoL in a mentally healthy elderly person	24
Widespread and progressive brain atrophy is a common feature in patients with mitochondrial disease	24
Precision diagnosis and precision treatment for the genetic epilepsies	24
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis	24
Hypothalamic atrophy in CANVAS/RFC1	24
Measuring the functional impact of cognitive impairment in Huntington’s disease	24
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry	24
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort	24
Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals	24
Ocular phenotype and electroretinogram abnormalities in Lafora disease and correlation with disease stage	24
Novel biomarkers and neuroimaging techniques in Parkinson’s disease	24
Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)	24
Recurrence and long-term outcomes of Tolosa-Hunt syndrome	24
Different approaches to test orientation of self in space: comparison of a 2D pen-and-paper test and a 3D real-world pointing task	23
The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register	23
Correction: Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas	23
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study	23
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications	23

Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis	23
How to identify insular epilepsy	23
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum	23
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies	23
Overcoming traps and pitfalls leading to misinterpretation of normal EEG variants and variation of the background activity	23
Frida Kahlo could have had cauda equina syndrome: a case report	23
Comparing caloric and self-experienced dizziness symptoms: diagnostic value and implications in functional dizziness	23
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	22
Case report: anti-argonaute antibodies in Epstein-Barr virus encephalitis	22
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases	22
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study	22
Incidence of cerebral small vessel disease-related MR markers in the Swedish general population ‘Good Aging in Skåne’(GÅS) study	22
Frequency and predictors of poststroke epilepsy after mechanical thrombectomy for large vessel occlusion stroke: results from a multicenter cohort study	22
Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis	22
The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis	22
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim	22
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study	22
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre	22
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments	22
Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces	22
Measurement of upper limb function in ALS: a structured review of current methods and future directions	22
Late-onset cerebellar ataxia in three European patients with repeat expansions in RFC1 and FGF14: a case series	22
The impact of spontaneous intracranial hypotension on social life and health-related quality of life	22
Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis—a single-center case series and pooled individual patient data meta-analysis	21
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision	21
Treatment of functional neurological disorder: an umbrella review of systematic reviews and meta-analyses	21
Photophobia in headache disorders: characteristics and potential mechanisms	21
Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank	21
Locus coeruleus degeneration and cerebellar gray matter changes in essential tremor	21
Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis	21
Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study	21
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis	21
Refractory focal epilepsy evolving into a Lennox–Gastaut syndrome-like	21
Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case–control study	21
Systematic assessment of square-wave jerks in progressive supranuclear palsy: a video-oculographic study	21
Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3	21
Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study	21
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A	21
Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis	21
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings	20
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption	20
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis	20
Good vibrations: tactile cueing for freezing of gait in Parkinson’s disease	20
A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk	20
Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy	20
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis	20
CSF phospho-tau levels at Parkinson’s disease onset predict the risk for development of motor complications	20
The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis	20
Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis	20
Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies	20
Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis	20
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype?	20
Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease	20
Motor and non-motor outcome in tremor dominant Parkinson’s disease after MR-guided focused ultrasound thalamotomy	20
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19	20
The effects of dopaminergic medication and task load on trembling and akinetic freezing of gait in Parkinson’s disease	20
Conjugate torsional pendular nystagmus and palatal tremor after unilateral internuclear ophthalmoplegia	20
Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders	20
Resurrection of sildenafil: potential for Huntington’s Disease, too?	20
Diagnosing primary lateral sclerosis: a clinico-pathological study	20
Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway	19
Motor function in multiple sclerosis assessed by navigated transcranial magnetic stimulation mapping	19
Explaining cognitive function in multiple sclerosis through networks of grey and white matter features: a joint independent component analysis	19
Referral trajectories in patients with vertigo, dizziness and balance disorders and their impact on health-related quality of life and functioning: results from the longitudinal multicenter study Mobi	19
Time course of lesion-induced atrophy in multiple sclerosis	19
A novel phenotype in an Italian family with a rare progranulin mutation	19
A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection	19
Eye movement abnormalities in normal pressure hydrocephalus: a video-oculographic study	19
A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies	19
Correction to: Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis	19
(William) Ritchie Russell (1903–1980)	19
Radiologically isolated syndromes: to treat or not to treat?	19
NMOSD typical brain lesions after COVID-19 mRNA vaccination	19
A survey-based approach on restless legs syndrome: practices and perspectives among Italian neurologists	19
Combined central and peripheral demyelination after COVID-19 vaccination	19
Olfactory dysfunction is common in classical infratentorial superficial siderosis of the central nervous system	19
Upper motor neuron-predominant motor neuron disease: a novel immunotherapy-responsive association of GAD65 autoimmunity	19
The impact of an MSU service on acute stroke care in a middle-sized city: a simulation-based analysis	19
Louis Jacobsohn-Lask (1863–1940)	19
Leg stereotypy syndrome: phenomenological and quantitative analysis	19
Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report	19
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages	19
A nationwide epidemiological study of myasthenia gravis in Turkey	19
NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease	19
Microvascular involvement in migraine: an optical coherence tomography angiography study	18
Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients	18
Movement disorders in autoimmune encephalitis: an update	18
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study	18
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort	18
Understanding social media: how its popularity could be used to advance medical education in stroke care?	18
Comparison of clinical features in patients with vestibular migraine and migraine	18
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?	18
Sleep characteristics and risk of Alzheimer’s disease: a systematic review and meta-analysis of longitudinal studies	18
Neurosarcoidosis	18
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility	18